XML 133 R64.htm IDEA: XBRL DOCUMENT
v3.23.1

Transactions with related parties (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2022
Disclosure of transactions between related parties [abstract] |
Executive Officers and Non-Executive Directors Compensation |
|  | Executive Officers |  | Non-Executive Directors |  | Total |
(USD millions) |  | 2022 |  | 2021 |  | 2020 |  | 2022 |  | 2021 |  | 2020 |  | 2022 |  | 2021 |  | 2020 |
Cash and other compensation |  | 25.0 |  | 20.3 |  | 25.6 |  | 4.6 |  | 4.7 |  | 4.6 |  | 29.6 |  | 25.0 |  | 30.2 |
Post-employment benefits |  | 2.8 |  | 2.5 |  | 2.7 |  |  |  |  |  |  |  | 2.8 |  | 2.5 |  | 2.7 |
Equity-based compensation |  | 42.6 |  | 37.3 |  | 41.1 |  | 4.8 |  | 5.2 |  | 5.2 |  | 47.4 |  | 42.5 |  | 46.3 |
Total |  | 70.4 |  | 60.1 |  | 69.4 |  | 9.4 |  | 9.9 |  | 9.8 |  | 79.8 |  | 70.0 |  | 79.2 |
Transactions with former members of the Board of Directors |
|  | Currency |  | 2022 |  | 2021 |  | 2020 |
Dr. Krauer |  | CHF |  |  |  | 60 000 |  | 60 000 |
Dr. Alex Krauer, was an Honorary Chairman of Novartis and was entitled to an amount of CHF 60 000 for annual periods from one AGM to the next. This amount was fixed in 1998 upon his departure from the Board in 1999. The last payment under this arrangement was in 2021.

X
- References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_OfficerAndDirectorCompensationTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_TransactionsWithFormerMembersOfTheBoardOfDirectorsTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration